tirzepatide adolescent Once Weekly in Children and Adolescents with Type 2 Diabetes (SURPASS-Peds). The New England Journal of Medicine. 2024;391:XXX–XXX. doi:10.1056/NEJMoa2400938 A Study of Tirzepatide (LY3298176)

What the Research Shows The approval was based on impressive results from the SURMOUNT-OSA clinical trials involving 469 adults: For people NOT using CPAP machines: Tirzepatide reduced breathing interruptions by 25 events per hour Placebo only reduced interruptions by 5 events per hour 42% achieved remission or mild symptoms after one year For people USING CPAP machines: Tirzepatide reduced breathing interruptions by 29 events per hour Placebo only reduced interruptions by 6 events per hour 50% achieved remission or mild symptoms after one year Beyond Sleep Apnea While sleep apnea research is most advanced, early evidence suggests GLP-1 medications may help with other sleep problems too: Reduced insomnia symptoms Less tossing and turning at night Improved deep sleep quality Better daytime energy levels Who Can Benefit From GLP-1 Therapy for Sleep

NICE guidance (NG28) recommends GLP-1 therapy for type 2 diabetes when metformin and other oral medications haven't achieved adequate control, typically in combination with insulin or as an alternative to insulin in specific circumstances

Foods to Avoid While Taking Semaglutide 1

In spite of the substantially reduced coupling to G s , exendinphe1 acts as a full agonist for acute cAMP production in pancreatic beta cells as well as heterologous cell lines (Jones, Bloom, et al., 2018), presumably due to the availability of spare receptors and signal amplification

[59] Within the cell, vitamin K participates in a cyclic process

While human clinical trials have not yet been completed, the existing data provides valuable insight into how the compound works and what effects it produces